ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 277

Rheumatic Conditions Appearing De Novo after Infection with Chikungunya Virus in Venezuelan Patients

Yurilis Fuentes-Silva1, Carlota Acosta2, Luisa Ortega3, Martin A Rodriguez4, Soham Al Snih5, Ivan Amaya6 and Irama Maldonado3, 1Division of Rheumatology/Internal Medicine Department, 1Unidad de Reumatología adscrita al Centro Nacional de Enfermedades Reumáticas. Complejo Hospitalario Universitario Ruiz y Páez, Ciudad Bolivar, Venezuela (Bolivarian Republic of), 21Unidad de Reumatología adscrita al Centro Nacional de Enfermedades Reumáticas. Complejo Hospitalario Universitario Ruiz y Páez, Ciudad Bolivar, Venezuela (Bolivarian Republic of), 3Internal Medicine, 1Unidad de Reumatología adscrita al Centro Nacional de Enfermedades Reumáticas. Complejo Hospitalario Universitario Ruiz y Páez, Ciudad Bolivar, Venezuela (Bolivarian Republic of), 4Division of Rheumatology/Internal Medicine Department, Centro Nacional de Enfermedades Reumaticas. Hospital Universitario de Caracas, Caracas, Venezuela (Bolivarian Republic of), 5University of Texas Medical Branch, Galveston, TX, 6Facultad de Bioanálisis. Universidad de Oriente, Cudad Bolivar, Venezuela (Bolivarian Republic of)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, infection and viruses

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: It is well known that viral infections can trigger autoimmune rheumatic diseases. In 2,014 there was an outbreak of Chikungunya (CHIK) virus infection in Venezuela. A majority of infected patients develop a flare of self-limited acute polyarthritis followed by complete remission. Some patients continue to experience subacute and chronic joint inflammatory symptoms. However, it is not well known how many of those patients evolve into a well-defined chronic rheumatic condition. The aim of this study was to examine how many patients with post-CHIK chronic inflammatory rheumatism (CHIK-CIR) evolve into a definite chronic rheumatic disease.

Methods: One hundred and sixty-eight patients seen during the period between 2,014 and 2,016 were included in this study. Post-CHIK CIR criteria were: 1. A triad of arthritis, fever and rash in presence of musculoskeletal manifestations (N=50, 29.76%) or 2. Musculoskeletal manifestations with or without the whole triad plus a positive IgM o IgG CHIK serology ELISA test (N=118, 70.23%). In both cases persistence of the symptoms for more than three months was required. The diagnosis for a definite rheumatic disease was done following the corresponding American College of Rheumatology (ACR) criteria. Statistical analysis was done by Chi-square and the Exact Fisher´s test. P-values of < 0.001 were considered statistically significant. All patients signed an informed consent.

Results: A positive CHIK serology test was tested and resulted positive in 70.23% of patients (IgM and IgG in 44 and 117 patients, respectively). Rheumatoid factor (RF) was positive in 24.13% and anti-citrullinated peptide antibodies (ACPA) in 25.66% of the patients. Of the total population (168 patients) with post-CHIK-CIR, 89.29% were female, mean age was 55.33 ± 12.72 years, and mean disease follow-up was 73.9±15.6 months. Forty patients (23.80%) had family history for autoimmunity. Thirty patients (17.85%) evolved into the following definite rheumatic diseases: rheumatoid arthritis (12.50%), psoriatic arthritis (2.38%), spondyloarthritis (1.79%) and systemic lupus erythematosus (0.60%). There was a statistically significant association between positivity of RF, ACPA or both with development of the de novo rheumatic diseases (P < 0.0001 in each case). Other variables studied no related with development of de novo rheumatic disease were: IgM and IgG serology titers, presence of tenosynovitis and elevation of acute phase reactants.

Conclusion: CHIK virus infection can trigger a chronic autoimmune rheumatic disease, predominantly rheumatoid arthritis. Risk factors are the appearance of either RF or ACPA, or both.


Disclosure: Y. Fuentes-Silva, None; C. Acosta, None; L. Ortega, None; M. A. Rodriguez, None; S. Al Snih, None; I. Amaya, None; I. Maldonado, None.

To cite this abstract in AMA style:

Fuentes-Silva Y, Acosta C, Ortega L, Rodriguez MA, Al Snih S, Amaya I, Maldonado I. Rheumatic Conditions Appearing De Novo after Infection with Chikungunya Virus in Venezuelan Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/rheumatic-conditions-appearing-de-novo-after-infection-with-chikungunya-virus-in-venezuelan-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatic-conditions-appearing-de-novo-after-infection-with-chikungunya-virus-in-venezuelan-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology